Inosine 5′-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients-Reference-Cited by-同舟云学术

Inosine 5′-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients

Published:2020-06-01 Issue:4 Volume:105 Page:916-927
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Glander Petra,Waiser Johannes,Hambach Pia,Bachmann Friederike,Budde Klemens,Eckardt Kai-Uwe,Friedersdorff Frank,Gaedeke Jens,Kron Susanne,Lorkowski Christine,Mai Marco,Neumayer Hans-H.,Peters Robert,Rudolph Birgit,Schmidt Danilo,Wu Kaiyin,Liefeldt Lutz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference47 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients.;Am J Transplant,2009

2. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.;Lancet,1995

3. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.;Sollinger;Transplantation,1995

4. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.;Salvadori;Am J Transplant,2004

5. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.;Budde;Am J Transplant,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor-derived cell-free DNA as a marker of graft injury after solid organ transplantation;Therapeutic Drug Monitoring;2024

2. Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using Ex Vivo T Cell Function Assays;Pharmaceutics;2023-05-31

3. Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches;Frontiers in Pharmacology;2022-10-26

4. Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients;JCI Insight;2022-05-09

5. Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial;Trials;2022-04-08